Early detection and early intervention have the potential to improve the prospects of recovery and positive outcomes for a broad range of diseases, including coronavirus. And now researchers in Europe believe they have found a method that uses a COVID-19 patient’s blood count to guide treatment and improve case outcomes. Here is an overview: The Diagnostic Challenge COVID-19 spans a wide clinical spectrum ranging from asymptomatic to severe pneumonia with multiple organ failure, and death. Early identification of critical patients requiring more aggressive intervention could go a long way in reducing COVID-19 deaths. But from almost the moment the pandemic began, the paramount objective of COVID-19 diagnostics has been to determine whether a person does or does not have the virus. Collecting information to guide medical treatment and improve clinical outcomes of patients who do have COVID-19 has received far less attention. The initial emphasis on detection is understandable given how contagious the virus is and the fact that treatments for it remain largely unproven. However, as the crisis drags on and deepens, an increasing number of researchers have been delving into the treatment aspects of COVID-19 diagnostics. The CBC Prognosis Test: Concept One notable example of fruitful outcomes-based COVID-19 […]